Your health, our priority – We offer you the finest treatment with personalized care that goes beyond treatment. Reach out to us today.
Hairy cell leukemia treatment cost in India starts from 3,000 USD and can go up to 6,000 USD, depending on the type of procedure, the patient’s condition, and the type of hospital one chooses.
| Treatment Type | Cost Range (INR) | Cost Range (USD) |
| Chemotherapy (Cladribine/Pentostatin) | ₹1,50,000 – ₹2,50,000 | $1,800 – $3,000 |
| Targeted Therapy (BRAF Inhibitors) | ₹1,80,000 – ₹3,50,000 | $2,200 – $4,200 |
| Immunotherapy (Rituximab) | ₹1,00,000 – ₹2,00,000 | $1,200 – $2,400 |
| Diagnostic Workup | ₹20,000 – ₹50,000 | $240 – $600 |
Note: Please keep in mind that the cost share above is only for the treatment. The final costing will depend on the completion of the treatment. Please coordinate with your healthcare provider for more details.
There are various key factors that can affect hairy cell leukemia treatment cost in India. Here are the following:
Type of Treatment: The cost varies depending on whether the patient undergoes chemotherapy, targeted therapy, immunotherapy, or combination treatments. Targeted therapy and immunotherapy are usually more expensive than standard chemotherapy.
Stage & Severity of Cancer: Early-stage HCL may require fewer treatment cycles, whereas relapsed or advanced cases often need additional therapy, increasing overall costs.
Hospital Type & Accreditation: Private and JCI/NABH-accredited hospitals generally charge higher fees than government hospitals or smaller clinics due to advanced infrastructure and facilities.
Doctor’s Expertise: Highly experienced hematologists or oncologists with specialized expertise in leukemia may have higher consultation and procedure fees.
City or Location: Costs are typically higher in metropolitan cities like Delhi, Mumbai, Bangalore, and Chennai compared to smaller towns due to operational and living expenses.
Diagnostic Tests & Pre-Treatment Workup: Tests such as bone marrow biopsy, flow cytometry, blood tests, and BRAF mutation analysis contribute to the overall cost.
Hospitalization & Supportive Care: Inpatient stays, blood transfusions, growth factor injections, and post-therapy monitoring can increase expenses.
Medications & Number of Cycles: The total cost depends on number of chemotherapy cycles, doses of immunotherapy, or duration of targeted therapy. Branded medications are costlier than generics.
Additional Procedures or Complications: If complications arise, additional interventions or longer hospital stays may further increase costs.
Given below are the names of the hospitals that is known for providing one of the best treatments for conditions like hairy cell leukemia in India:
Hairy-cell leukemia is an uncommon and persistent form of B-cell leukemia. Under a microscope, aberrant B cells with “hairy” projections are their defining feature. The spleen and bone marrow are the primary organs affected by this slow-growing blood malignancy, which leads to immunological suppression and low blood counts.
In many instances, hairy-cell leukemia may not exhibit any signs in its early stages and frequently progresses slowly. But when the illness worsens, the aberrant accumulation of hairy cells in the blood, spleen, and bone marrow starts to interfere with the body’s natural ability to produce blood cells. It can lead to a range of physical symptoms and general health concerns.
Symptoms include:
Appropriate blood tests and a bone marrow examination are necessary for an appropriate diagnosis because these symptoms can also mimic those of other ailments, such as infections or different kinds of blood problems.
How is it diagnosed?
Advanced imaging, bone marrow analysis, and blood testing are all used to diagnose hairy-cell leukemia. A thorough and precise diagnosis is essential before beginning treatment because the illness is uncommon and shares symptoms with numerous other blood disorders.
Treatment for hairy-cell leukemia is very effective, and many patients experience long-lasting remission. The severity of symptoms, blood counts, spleen size, and the existence of infections all influence treatment. Some individuals with stable conditions and no symptoms might be watched without receiving treatment right away; this is known as “watchful waiting.”
The first-line treatment is chemotherapy.
Chemotherapy employing purine analogs like these is the most popular and successful first-line treatment for HCL.
- Cladribine (2-CdA): Usually administered as a subcutaneous injection or as a brief infusion lasting five to seven days. Up to 90% of patients experience remission.
- Pentostatin: Given intravenously every two weeks until the intended effect is obtained.
These medications function by focusing on the aberrant hairy cells and lowering their quantity in the blood and bone marrow. After a single course, the majority of patients get remission that lasts for several years.
Targeted Therapy
Targeted medicines, such the following, may be given to patients who relapse or do not react well to chemotherapy:
- BRAF inhibitors (vemurafenib): These are most successful in people with the BRAF V600E mutation.
- Moxetumomab pasudotox: A more recent FDA-approved medication that targets CD22 on malignant B cells. In cases of relapsed or refractory HCL, it is beneficial.
Compared to conventional chemotherapy, these treatments are more accurate and might have fewer adverse effects.
Rituximab, which targets CD20, is one example of a monoclonal antibody that may be administered alone in certain patients or added after chemotherapy. They aid in the immune system’s identification and elimination of malignant B cells.
Given below are some of the services provided for patients who come to India for treatment:
Al Afiya Medi Tour assists patients by putting them in touch with the best hospitals and doctors in India for a reasonable price. Treatment planning, medical consultations, visa assistance, airport pickup, lodging, translation services, and round-the-clock patient care are all included in their end-to-end support. Under their direction, foreign patients can easily and stress-free receive top-notch care in India.
Below are the list of the top hospitals that are known for Hairy Cell Leukemia Treatment Cost in India procedures:
Established in: 2004
Number of Beds: 240
Super Specialty
Location: Mumbai
Established in: 2024
Number of Beds: 300
Multi Specialty
Location: New Delhi
Established in: 2013
Number of Beds: 300
Multi Specialty
Location: Bangalore
Established in:
Multi Specialty
Location: Bangalore
Established in: 2011
Number of Beds: 300
Super Specialt
Location: New Delhi
Established in: 1954
Number of Beds: 575
Multi Specialty
Location: New Delhi
Established in: 2014
Number of Beds: 200
Multi Specialty
Location: Hyderabad
Established in: 2001
Number of Beds: 310
Multi Speciality
Location: Gurgaon
Established in: 1999
Number of Beds: 1000
Multi Specialty
Location: Chennai
Established in: 1989
Number of Beds: 500
Multi Specialty
Location: Secunderabad, Hyderabad
Transparent • Professional • Without Hassles
Get detailed cost breakdowns and compare prices across multiple hospitals
Schedule appointments with top specialists at your convenience
Complete assistance from admission to discharge with dedicated care
Consult doctors online or in-person based on your preference
Visa support, flight booking, and airport pickup services
Multilingual support to ensure clear communication
Comfortable stay arrangements near the hospital
Round-the-clock assistance for all your medical needs
4.0
Experience: 28
Education: MBBS, MD, DNB, DM, MBA
Get a free consultancy
4.0
Experience: 29
Education: MBBS, MS. DNB MRCS(Edin), MNAMS, FIAGES
Get a free consultancy
4.0
Experience: 20 years of experience
Education: Director , MBBS, MD, DM
Get a free consultancy
4.0
Experience: 27
Education: MBBS , MS , Fellowship
Get a free consultancy
4.0
Experience: 27
Education: MBBS, MS, DNB
Get a free consultancy
4.0
Experience: 33 Years of Experience
Education: Director , MBBS, MS
Get a free consultancy
4.0
Experience: 32
Education: MBBS, MS, MCh, DNB, FAIS, FAMS
Get a free consultancy
4.0
Experience: 20
Education: MBBS , MD , DM
Get a free consultancy
4.0
Experience: 15
Education: MBBS, MD, DM
Get a free consultancy
4.0
Experience: 37
Education: MBBS, MD, DNB, Fellowship
Get a free consultancy
Fill out the form below and our team will get back to you shortly
Q: How does Hairy Cell Leukemia vary from other types of leukemia?
A: A rare, slow-growing blood malignancy that affects B cells, hairy cell leukemia is identified by the “hair-like” projections on leukemia cells and usually involves the BRAF V600E mutation.
Q: Is it possible to cure Hairy Cell Leukemia?
A: HCL is quite treatable even though it isn’t typically thought to be cured. With the right care and consistent observation, many patients experience long-term remission.
Q: What is the duration of HCL treatment?
A: Usually, chemotherapy is administered over five to seven days. The majority of patients show recovery in a few weeks, and follow-up care is given over a number of months.
Q: Does treatment necessitate hospitalization?
A: While some chemotherapy can be given as an outpatient treatment, brief hospital stays (three to five days) are typical, particularly for initial treatments or managing side effects.